Humco Epson Salt Powder, For Solution
NDC Package 0395-0807-94
Package Information
Humco Epson Salt (magnesium sulfate) powders is for laxative use. This formulation utilizes a powder, for solution delivery system. Marketed by Humco Holding Group, Inc., this product is identified by NDC 0395-0807 and is authorized under FDA application M007.
Identification & Billing
- RxCUI: 1053346 - Epsom salt 100 % Granules for Oral Solution
- RxCUI: 1053346 - magnesium sulfate 1000 MG Granules for Oral Solution
- RxCUI: 1053346 - magnesium sulfate 100 % Granules for Oral Solution
Clinical Specifications
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 0395 - Humco Holding Group, Inc.
- 0395-0807 - Humco Epson Salt
- 0395-0807-94 - 113 g in 1 BOTTLE, PLASTIC
- 0395-0807 - Humco Epson Salt
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0395-0807). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0395-0807-94 identifies a specific commercial package of 113 g in 1 bottle, plastic of Humco Epson Salt, a human over the counter drug labeled by Humco Holding Group, Inc.. This powder, for solution is formulated for oral use and contains magnesium sulfate heptahydrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Humco Holding Group, Inc. on March 25, 1998. The current certification is valid through December 31, 2026.
How is this Humco Holding Group, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00395080794. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.